---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-001602"
form_type: "8-K"
ticker: "CRVS"
cik: "0001626971"
company_name: "Corvus Pharmaceuticals, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:29:34.148361+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Corvus Pharmaceuticals confirms no cash or securities at Silicon Valley Bank

## Summary
- Corvus Pharmaceuticals, on March 10, 2023, stated it does not hold cash deposits or securities at Silicon Valley Bank.
- The disclosure addresses investor concerns after Silicon Valley Bank's collapse.
- Company's liquidity unaffected by SVB failure; no cash or securities at risk.

## SEC filing metadata
- accession: 0001171843-23-001602
- form_type: 8-K
- ticker: CRVS
- cik: 0001626971
- company_name: Corvus Pharmaceuticals, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626971/000117184323001602/0001171843-23-001602-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626971/000117184323001602/f8k_031023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-001602
- JSON: https://secwatch.observer/filing/0001171843-23-001602.json
- Plain text: https://secwatch.observer/filing/0001171843-23-001602.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.